Baxter ROE 2010-2024 | BAX

Current and historical return on equity (ROE) values for Baxter (BAX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Baxter ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $-0.65B $7.02B -8.40%
2024-09-30 $0.11B $7.94B 1.34%
2024-06-30 $2.48B $7.71B 30.40%
2024-03-31 $2.65B $8.24B 34.74%
2023-12-31 $2.66B $8.47B 37.67%
2023-09-30 $2.59B $8.17B 40.45%
2023-06-30 $-2.85B $5.63B -49.52%
2023-03-31 $-2.46B $5.94B -37.39%
2022-12-31 $-2.43B $5.90B -32.99%
2022-09-30 $-2.38B $5.58B -29.04%
2022-06-30 $1.01B $8.90B 11.25%
2022-03-31 $1.06B $9.12B 11.88%
2021-12-31 $1.28B $9.12B 14.69%
2021-09-30 $1.21B $8.82B 14.05%
2021-06-30 $1.12B $8.54B 13.04%
2021-03-31 $1.07B $8.49B 12.57%
2020-12-31 $1.10B $8.73B 13.27%
2020-09-30 $0.91B $8.60B 11.25%
2020-06-30 $0.92B $8.16B 11.76%
2020-03-31 $0.99B $7.73B 12.75%
2019-12-31 $1.00B $7.91B 12.90%
2019-09-30 $1.32B $7.62B 17.04%
2019-06-30 $1.47B $7.84B 18.09%
2019-03-31 $1.50B $7.67B 17.89%
2018-12-31 $1.55B $7.87B 17.70%
2018-09-30 $1.06B $9.11B 11.76%
2018-06-30 $0.80B $8.87B 8.73%
2018-03-31 $0.72B $9.09B 7.81%
2017-12-31 $0.60B $9.12B 6.61%
2017-09-30 $1.03B $9.46B 11.59%
2017-06-30 $0.91B $9.17B 10.46%
2017-03-31 $1.86B $8.68B 21.76%
2016-12-31 $4.97B $8.28B 57.61%
2016-09-30 $4.93B $8.66B 56.21%
2016-06-30 $4.80B $8.51B 56.05%
2016-03-31 $3.92B $9.02B 46.43%
2015-12-31 $0.97B $8.87B 12.09%
2015-09-30 $1.72B $7.85B 21.92%
2015-06-30 $2.18B $8.02B 27.38%
2015-03-31 $2.37B $7.29B 29.13%
2014-12-31 $2.50B $8.16B 29.41%
2014-09-30 $1.87B $8.43B 21.81%
2014-06-30 $1.95B $8.69B 23.16%
2014-03-31 $2.02B $8.69B 25.01%
2013-12-31 $2.01B $8.49B 26.35%
2013-09-30 $2.18B $7.75B 30.03%
2013-06-30 $2.22B $7.32B 31.16%
2013-03-31 $2.29B $7.00B 32.97%
2012-12-31 $2.33B $6.98B 33.54%
2012-09-30 $2.30B $7.19B 33.27%
2012-06-30 $2.29B $6.61B 33.17%
2012-03-31 $2.24B $6.96B 31.77%
2011-12-31 $2.22B $6.83B 31.51%
2011-09-30 $2.18B $7.19B 30.98%
2011-06-30 $2.13B $7.24B 30.72%
2011-03-31 $2.05B $6.97B 30.80%
2010-12-31 $1.42B $6.80B 21.55%
2010-09-30 $1.57B $6.76B 23.27%
2010-06-30 $1.57B $6.13B 22.87%
2010-03-31 $1.63B $6.66B 23.09%
2009-12-31 $2.21B $7.42B 31.88%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $16.360B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.641B 27.61
Boston Scientific (BSX) United States $152.191B 38.10
Stryker (SYK) United States $148.126B 30.97
EssilorLuxottica (ESLOY) France $127.448B 0.00
Medtronic (MDT) Ireland $110.055B 16.07
Lonza Group Ag (LZAGY) Switzerland $49.786B 0.00
Haleon (HLN) United Kingdom $48.281B 27.46
ResMed (RMD) United States $36.314B 27.27
GE HealthCare Technologies (GEHC) United States $33.934B 16.11
Agilent Technologies (A) United States $32.944B 21.76
Terumo (TRUMY) Japan $28.086B 0.00
Koninklijke Philips (PHG) Netherlands $23.536B 16.92
Insulet (PODD) United States $22.286B 87.48
Zimmer Biomet Holdings (ZBH) United States $19.433B 12.48
Smith & Nephew SNATS (SNN) United Kingdom $12.456B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $7.190B 24.31
Lantheus Holdings (LNTH) United States $5.502B 13.88
Prestige Consumer Healthcare (PBH) United States $4.350B 19.43
Perrigo (PRGO) Ireland $3.711B 9.40
ICU Medical (ICUI) United States $3.552B 26.20
Haemonetics (HAE) United States $3.528B 15.37
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.144B 26.13
QuidelOrtho (QDEL) United States $2.531B 17.41
GN Store Nord (GNNDY) Denmark $2.188B 18.12
LeMaitre Vascular (LMAT) United States $1.863B 41.65
AtriCure (ATRC) United States $1.575B 0.00
Neogen (NEOG) United States $1.411B 18.06
AdaptHealth (AHCO) United States $1.229B 12.48
Kestra Medical Technologies (KMTS) United States $1.211B 0.00
Green Thumb Industries (GTBIF) United States $1.152B 25.91
BioLife Solutions (BLFS) United States $1.135B 0.00
InMode (INMD) Israel $1.043B 9.55
Phibro Animal Health (PAHC) United States $0.992B 12.69
Evolus (EOLS) United States $0.643B 0.00
CeriBell (CBLL) United States $0.620B 0.00
Owens & Minor (OMI) United States $0.552B 4.58
Curaleaf Holdings (CURLF) Canada $0.545B 0.00
Valneva SE (VALN) France $0.539B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.539B 0.00
Tilray Brands (TLRY) Canada $0.462B 0.00
Surmodics (SRDX) United States $0.387B 0.00
Cresco Labs (CRLBF) United States $0.357B 0.00
SNDL (SNDL) Canada $0.347B 0.00
Capricor Therapeutics (CAPR) United States $0.325B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
VAREX IMAGING (VREX) United States $0.310B 11.39
Sanara MedTech (SMTI) United States $0.305B 0.00
Aurora Cannabis (ACB) Canada $0.284B 50.60
Canopy Growth (CGC) Canada $0.268B 0.00
Sanuwave Health (SNWV) United States $0.261B 0.00
Cerus (CERS) United States $0.258B 0.00
Viemed Healthcare (VMD) United States $0.257B 21.70
ZimVie (ZIMV) United States $0.248B 11.28
Verano Holdings (VRNOF) United States $0.248B 0.00
Quanterix (QTRX) United States $0.222B 0.00
Omeros (OMER) United States $0.221B 0.00
Biote (BTMD) United States $0.218B 6.14
OraSure Technologies (OSUR) United States $0.200B 0.00
High Tide (HITI) Canada $0.192B 0.00
Utah Medical Products (UTMD) United States $0.177B 14.29
Organigram Global (OGI) Canada $0.171B 0.00
Brainsway (BWAY) Israel $0.167B 51.94
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
FitLife Brands (FTLF) United States $0.145B 17.82
Jin Medical (ZJYL) China $0.141B 0.00
Exagen (XGN) United States $0.123B 0.00
TerrAscend (TSNDF) Canada $0.107B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Agape ATP (ATPC) $0.083B 0.00
Fonar (FONR) United States $0.077B 10.76
Veru (VERU) United States $0.076B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
InterCure (INCR) Israel $0.069B 0.00
Zynex (ZYXI) United States $0.065B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Apyx Medical (APYX) United States $0.042B 0.00
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 13.10
Safety Shot (SHOT) United States $0.037B 0.00
Rockwell Medical (RMTI) United States $0.036B 0.00
Nephros (NEPH) United States $0.022B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00